Stepwise differentiation from precursor intermediates and distinct Th1 checkpoints promote CD4 Th1 cell differentiation during chronic viral infection

CD4<sup>+</sup> helper T cells are essential for controlling viral infections. During chronic LCMV infection, CD4<sup>+</sup> T cells differentiate into heterogeneous populations, including a TCF-1<sup>hi</sup> progenitor subset that serves as a reservoir to continuously replenish type 1 helper (Th1) and follicular helper (Tfh) T cells. The gradual loss of CD4<sup>+</sup> Th1 cell responses impairs the immune system's ability to control viral replication and contributes to the development of CD8<sup>+</sup> T cell exhaustion. However, the mechanisms directing Th1 differentiation and the factors underlying their progressive decline during chronic infection remain poorly understood. In this study, we delineate the stepwise differentiation trajectory of Th1 cells, tracing their progression from TCF-1<sup>hi</sup> progenitors through an intermediate state to fully differentiated Th1 cells. We identify an intermediate CD4<sup>+</sup> T cell subset that serves as a precursor to Th1 cells, demonstrate that PD-1/PD-L1 signaling suppresses the transition from the progenitor to intermediate state, whereas the chromatin-remodeling complex PBAF restricts the terminal differentiation of CD4<sup>+</sup> T cells into the Th1 subset. Notably, the combined blockade of PD-1/PD-L1 and genetic ablation of PBAF component (ARID2) additively enhanced Th1 differentiation and maintenance, leading to effective viral control. Thus, targeting these mechanisms driving CD4 Th1 cell differentiation and maintenance could enhance therapeutic strategies to restore Th1 function and control chronic infection.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-01-30
DOI
https://doi.org/10.1073/pnas.2522928123
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stepwise differentiation from precursor intermediates and distinct Th1 checkpoints promote CD4 Th1 cell differentiation during chronic viral infection

Siying Lin, Hongshen Niu, Arjun Kharel, Ryan Brown et al.
Proceedings of the National Academy of Sciences
Cancer Immunotherapy and Biomarkers
article

Stepwise differentiation from precursor intermediates and distinct Th1 checkpoints promote CD4 Th1 cell differentiation during chronic viral infection

Siying Lin, Hongshen Niu, Arjun Kharel, Ryan Brown, Ashley K. Brown, David G. Brooks, Weiguo Cui, Jian Shen, Ashley M. Bauer, Ziyang Xu, Kexin Gai, Yuqi Zhang
article en

Abstract

CD4<sup>+</sup> helper T cells are essential for controlling viral infections. During chronic LCMV infection, CD4<sup>+</sup> T cells differentiate into heterogeneous populations, including a TCF-1<sup>hi</sup> progenitor subset that serves as a reservoir to continuously replenish type 1 helper (Th1) and follicular helper (Tfh) T cells. The gradual loss of CD4<sup>+</sup> Th1 cell responses impairs the immune system's ability to control viral replication and contributes to the development of CD8<sup>+</sup> T cell exhaustion. However, the mechanisms directing Th1 differentiation and the factors underlying their progressive decline during chronic infection remain poorly understood. In this study, we delineate the stepwise differentiation trajectory of Th1 cells, tracing their progression from TCF-1<sup>hi</sup> progenitors through an intermediate state to fully differentiated Th1 cells. We identify an intermediate CD4<sup>+</sup> T cell subset that serves as a precursor to Th1 cells, demonstrate that PD-1/PD-L1 signaling suppresses the transition from the progenitor to intermediate state, whereas the chromatin-remodeling complex PBAF restricts the terminal differentiation of CD4<sup>+</sup> T cells into the Th1 subset. Notably, the combined blockade of PD-1/PD-L1 and genetic ablation of PBAF component (ARID2) additively enhanced Th1 differentiation and maintenance, leading to effective viral control. Thus, targeting these mechanisms driving CD4 Th1 cell differentiation and maintenance could enhance therapeutic strategies to restore Th1 function and control chronic infection.

Proceedings of the National Academy of SciencesVol. 123(5)
Northwestern University (US), University of Toronto (CA), Medical College of Wisconsin (US), Princess Margaret Cancer Centre (CA)
Good health and well-being
Openalex Percentile: Top 73%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.